Suchergebnisse - "Bezzerides, Vassilios"

PubPharm (4)

1

An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor

enthalten in: Science translational medicine | 2023

von Reyes Gaido, O. | Pavlaki, N. | Granger, J. | +19

CommentIn: Nat Rev Cardiol. 2023 Sep;20(9):580. - PMID 37400626

2

Increased Reactive Oxygen Species-Mediated Ca2+/Calmodulin-Dependent Protein Kinase II Activation Contributes to Calcium Handling Abnormalities and Impaired Contraction in Barth Syndrome

enthalten in: Circulation | 2021

von Liu, X. | Wang, S. | Guo, X. | +16

3

MICAL1 constrains cardiac stress responses and protects against disease by oxidizing CaMKII

enthalten in: The Journal of clinical investigation | 2020

von Konstantinidis, K. | Bezzerides, V. | Lai, L. | +25

4

Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca2+/Calmodulin-Dependent Kinase II

enthalten in: Circulation | 2019

von Bezzerides, V. | Caballero, A. | Wang, S. | +8

CommentIn: Nat Rev Cardiol. 2019 Aug;16(8):456. - PMID 31189987

1
[1]